Avita Medical, Inc. cash flow statement
In fiscal 2025, Avita Medical, Inc.'s operations generated −$31.2m of cash; it spent $1.0m on capital projects, leaving free cash flow of −$32.2m.
Cash flow statement
| Fiscal year | 2018Jun 2018 | 2019Jun 2019 | 2020Jun 2020 | 2021Jun 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −13 | −19 | −23 | −26 | −19 | −38 | −49 | −31 | −24 |
| Depreciation and amortisation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 |
| Stock-based pay | 1 | 2 | 16 | 6 | 7 | 8 | 13 | 10 | 7 |
| Capital spending | 0 | 1 | 1 | 1 | 0 | 1 | 9 | 1 | 0 |
| Free cash flow | −13 | −20 | −23 | −27 | −20 | −39 | −58 | −32 | −25 |
| Free cash flow after stock pay | −15 | −22 | −40 | −32 | −27 | −48 | −72 | −42 | −32 |
| Shares issued | 23 | 32 | 82 | 69 | — | — | — | 15 | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −7 | −8 | −10 | −10 | −5 | −5 | −10 | −3 |
| Depreciation and amortisation | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 |
| Stock-based pay | 4 | 3 | 3 | 3 | 3 | 1 | 1 | 2 |
| Capital spending | 4 | 2 | 0 | 1 | 1 | −1 | 0 | 0 |
| Free cash flow | −11 | −10 | −11 | −11 | −6 | −5 | −10 | −4 |
| Free cash flow after stock pay | −15 | −12 | −13 | −13 | −9 | −6 | −11 | −6 |
| Shares issued | — | — | — | — | — | 0 | — | — |
Compare with peers
- Electromed, Inc. cash flow
- PRO DEX Inc cash flow
- Tela Bio, Inc. cash flow
- Sight Sciences, Inc. cash flow
- Pulmonx Corp cash flow
Head to head: ELMD vs RCELPDEX vs RCELRCEL vs TELA
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies